Complete Kawasaki disease after COVID-19 infection in an infant

Area of Science:

• Pediatrics
• Immunology
• Infectious Diseases

Background:

• Kawasaki disease is a systemic vasculitis of unknown etiology, potentially influenced by immune responses, genetics, and infections.
• The association between Kawasaki disease and COVID-19 in pediatric populations requires further investigation.

Observation:

• A 7-month-old male infant presented with classic symptoms of Kawasaki disease, including fever, rash, conjunctivitis, and oral mucosal changes.
• The infant tested positive for COVID-19 IgM antibodies, suggesting a recent infection.

Findings:

• The patient met the diagnostic criteria for Kawasaki disease.
• Treatment with intravenous immunoglobulin, methylprednisolone, and aspirin resulted in a normal echocardiogram at six weeks follow-up.

Implications:

• Clinicians should maintain a high index of suspicion for Kawasaki disease in pediatric patients presenting with COVID-19.
• Prompt diagnosis and intervention are vital to mitigate potential cardiac complications associated with Kawasaki disease in the context of COVID-19.
• Further prospective studies are necessary to elucidate the relationship between Kawasaki disease and COVID-19 infection.